Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

WADA to Introduce Steroid Passport by Year’s End, President Says

Sept. 10 (Bloomberg) -- World Anti-Doping Agency President John Fahey said a steroid passport will be introduced by the end of 2013 as the latest means of catching drug cheats.

The initiative will complement the biological passport, which measures changes in blood profile and can be used to detect differences from an athlete’s established levels that might indicate doping.

“The biological passport is a key component against doping and has been recognized by the courts as evidence,” Fahey said yesterday at the International Olympic Committee’s annual meeting in Buenos Aires.

Fahey, an Australian whose term as WADA president finishes at the end of this year, said the Montreal-based organization is likely to double the ban for first-time drug cheats from two to four years at its congress in Johannesburg in November.

“The athletes have demanded a tougher approach to cheats and instead of the current two-year ban, the penalty will be doubled for first offenders,” he said.

Officials at the Johannesburg meeting also will consider tighter regulation for coaches, trainers and sports scientists associated with athletes, Fahey added.

To contact the reporter on this story: Dan Baynes in Sydney at dbaynes@bloomberg.net

To contact the editor responsible for this story: Christopher Elser at celser@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.